<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id>
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta> 
    </front>
    <back>
        <ref-list>
            <ref id="b1">
                <label>1. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Singh</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Agusti</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Anzueto</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Barnes</surname>
                            <given-names>PJ</given-names>
                        </name>, 
                        <name>
                            <surname>Bourbeau</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Celli</surname>
                            <given-names>BR</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2019</year>
                    <month>May</month>;
                    <volume>53</volume>(
                    <issue>5</issue>):
                    <fpage>1900164</fpage>. 
                    <pub-id pub-id-type="doi">10.1183/13993003.00164-2019</pub-id>
                    <pub-id pub-id-type="pmid">30846476</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
            </ref>
            <ref id="b2">
                <label>2. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gibson</surname>
                            <given-names>PG</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>IA</given-names>
                        </name>, 
                        <name>
                            <surname>Upham</surname>
                            <given-names>JW</given-names>
                        </name>, 
                        <name>
                            <surname>Reynolds</surname>
                            <given-names>PN</given-names>
                        </name>, 
                        <name>
                            <surname>Hodge</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>James</surname>
                            <given-names>AL</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial</article-title>. 
                    <source>Lancet</source>. 
                    <year>2017</year>
                    <month>Aug</month>;
                    <volume>390</volume>(
                    <issue>10095</issue>):
                    <fpage>659</fpage>–
                    <lpage>68</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31281-3</pub-id>
                    <pub-id pub-id-type="pmid">28687413</pub-id>
                    <issn>0140-6736</issn>
                </mixed-citation>
            </ref>
            <ref id="b3">
                <label>3. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Macaluso</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Maritano Furcada</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Alzaher</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <name>
                            <surname>Chaube</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Chua</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Wells</surname>
                            <given-names>AU</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The potential impact of azithromycin in idiopathic pulmonary fibrosis</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2019</year>
                    <month>Feb</month>;
                    <volume>53</volume>(
                    <issue>2</issue>):
                    <fpage>1800628</fpage>. 
                    <pub-id pub-id-type="doi">10.1183/13993003.00628-2018</pub-id>
                    <pub-id pub-id-type="pmid">30442715</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
            </ref>
            <ref id="b4">
                <label>4. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Altenburg</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>de Graaff</surname>
                            <given-names>CS</given-names>
                        </name>, 
                        <name>
                            <surname>van der Werf</surname>
                            <given-names>TS</given-names>
                        </name>, 
                        <name>
                            <surname>Boersma</surname>
                            <given-names>WG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms</article-title>. 
                    <source>Respiration</source>. 
                    <year>2011</year>;
                    <volume>81</volume>(
                    <issue>1</issue>):
                    <fpage>67</fpage>–
                    <lpage>74</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000320319</pub-id>
                    <pub-id pub-id-type="pmid">20733281</pub-id>
                    <issn>1423-0356</issn>
                </mixed-citation>
            </ref>
            <ref id="b5">
                <label>5. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cirioni</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <name>
                            <surname>Ghiselli</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Silvestri</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Minardi</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Gabrielli</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Orlando</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection</article-title>. 
                    <source>J Antimicrob Chemother</source>. 
                    <year>2011</year>
                    <month>Jun</month>;
                    <volume>66</volume>(
                    <issue>6</issue>):
                    <fpage>1318</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jac/dkr107</pub-id>
                    <pub-id pub-id-type="pmid">21406436</pub-id>
                    <issn>0305-7453</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
                <label>6. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Black</surname>
                            <given-names>PN</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Anti-inflammatory effects of macrolide antibiotics</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>1997</year>
                    <month>May</month>;
                    <volume>10</volume>(
                    <issue>5</issue>):
                    <fpage>971</fpage>–
                    <lpage>2</lpage>. 
                    <pub-id pub-id-type="doi">10.1183/09031936.97.10050971</pub-id>
                    <pub-id pub-id-type="pmid">9163632</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
            </ref>
            <ref id="b7">
                <label>7. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Simpson</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Powell</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Baines</surname>
                            <given-names>KJ</given-names>
                        </name>, 
                        <name>
                            <surname>Milne</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Coxson</surname>
                            <given-names>HO</given-names>
                        </name>, 
                        <name>
                            <surname>Hansbro</surname>
                            <given-names>PM</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <chapter-title>The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial</chapter-title>. 
                    <source>PLoS One</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>9</volume>(
                    <issue>8</issue>):
                    <fpage>e105609</fpage>–
                    <lpage>e105609</lpage>. 
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0105609</pub-id>
                    <pub-id pub-id-type="pmid">25148049</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
            </ref>
            <ref id="b8">
                <label>8. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Asgrimsson</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Gudjonsson</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Gudmundsson</surname>
                            <given-names>GH</given-names>
                        </name>, 
                        <name>
                            <surname>Baldursson</surname>
                            <given-names>O</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Novel effects of azithromycin on tight junction proteins in human airway epithelia</article-title>. 
                    <source>Antimicrob Agents Chemother</source>. 
                    <year>2006</year>
                    <month>May</month>;
                    <volume>50</volume>(
                    <issue>5</issue>):
                    <fpage>1805</fpage>–
                    <lpage>12</lpage>. 
                    <pub-id pub-id-type="doi">10.1128/AAC.50.5.1805-1812.2006</pub-id>
                    <pub-id pub-id-type="pmid">16641453</pub-id>
                    <issn>0066-4804</issn>
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tojima</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Shimizu</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Ogawa</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Kouzaki</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Omura</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Sunazuka</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium</article-title>. 
                    <source>Auris Nasus Larynx</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>42</volume>(
                    <issue>4</issue>):
                    <fpage>332</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.anl.2015.02.003</pub-id>
                    <pub-id pub-id-type="pmid">25769240</pub-id>
                    <issn>0385-8146</issn>
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Suzuki</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Yamaya</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Sekizawa</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Hosoda</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Yamada</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Ishizuka</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2002</year>
                    <month>Apr</month>;
                    <volume>165</volume>(
                    <issue>8</issue>):
                    <fpage>1113</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/ajrccm.165.8.2103094</pub-id>
                    <pub-id pub-id-type="pmid">11956054</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tan</surname>
                            <given-names>WC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Viruses in asthma exacerbations</article-title>. 
                    <source>Curr Opin Pulm Med</source>. 
                    <year>2005</year>
                    <month>Jan</month>;
                    <volume>11</volume>(
                    <issue>1</issue>):
                    <fpage>21</fpage>–
                    <lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">15591884</pub-id>
                    <issn>1070-5287</issn>
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Seemungal</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Harper-Owen</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Bhowmik</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Moric</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Sanderson</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Message</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2001</year>
                    <month>Nov</month>;
                    <volume>164</volume>(
                    <issue>9</issue>):
                    <fpage>1618</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/ajrccm.164.9.2105011</pub-id>
                    <pub-id pub-id-type="pmid">11719299</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b13">
                <label>13. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kobrehel</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Lazarevski</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Dokić</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Kolacny-Babić</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Kucisec-Iepes</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Cvrlje</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Synthesis and antibacterial activity of O-methylazithromycin derivatives</article-title>. 
                    <source>J Antibiot (Tokyo)</source>. 
                    <year>1992</year>
                    <month>Apr</month>;
                    <volume>45</volume>(
                    <issue>4</issue>):
                    <fpage>527</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.7164/antibiotics.45.527</pub-id>
                    <pub-id pub-id-type="pmid">1317368</pub-id>
                    <issn>0021-8820</issn>
                </mixed-citation>
            </ref>
            <ref id="b14">
                <label>14. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Stepanić</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Žiher</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Gabelica-Marković</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Jelić</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Nunhuck</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Valko</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Physicochemical profile of macrolides and their comparison with small molecules</article-title>. 
                    <source>Eur J Med Chem</source>. 
                    <year>2012</year>
                    <month>Jan</month>;
                    <volume>47</volume>(
                    <issue>1</issue>):
                    <fpage>462</fpage>–
                    <lpage>72</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.11.016</pub-id>
                    <pub-id pub-id-type="pmid">22152985</pub-id>
                    <issn>0223-5234</issn>
                </mixed-citation>
            </ref>
            <ref id="b15">
                <label>15. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Taylor</surname>
                            <given-names>SP</given-names>
                        </name>, 
                        <name>
                            <surname>Sellers</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Taylor</surname>
                            <given-names>BT</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Azithromycin for the prevention of COPD exacerbations: the good, bad, and ugly</article-title>. 
                    <source>Am J Med</source>. 
                    <year>2015</year>
                    <month>Dec</month>;
                    <volume>128</volume>(
                    <issue>12</issue>):
                    <fpage>1362.e1</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.amjmed.2015.07.032</pub-id>
                    <pub-id pub-id-type="pmid">26291905</pub-id>
                    <issn>0002-9343</issn>
                </mixed-citation>
            </ref>
            <ref id="b16">
                <label>16. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kudoh</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Erythromycin treatment in diffuse panbronchiolitis</article-title>. 
                    <source>Curr Opin Pulm Med</source>. 
                    <year>1998</year>
                    <month>Mar</month>;
                    <volume>4</volume>(
                    <issue>2</issue>):
                    <fpage>116</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/00063198-199803000-00010</pub-id>
                    <pub-id pub-id-type="pmid">9612675</pub-id>
                    <issn>1070-5287</issn>
                </mixed-citation>
            </ref>
            <ref id="b17">
                <label>17. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kudoh</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Azuma</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Yamamoto</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Izumi</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Ando</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>1998</year>
                    <month>Jun</month>;
                    <volume>157</volume>(
                    <issue>6 Pt 1</issue>):
                    <fpage>1829</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/ajrccm.157.6.9710075</pub-id>
                    <pub-id pub-id-type="pmid">9620913</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b18">
                <label>18. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Castellani</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Duff</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Bell</surname>
                            <given-names>SC</given-names>
                        </name>, 
                        <name>
                            <surname>Heijerman</surname>
                            <given-names>HG</given-names>
                        </name>, 
                        <name>
                            <surname>Munck</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Ratjen</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>ECFS best practice guidelines: the 2018 revision</article-title>. 
                    <source>J Cyst Fibros</source>. 
                    <year>2018</year>
                    <month>Mar</month>;
                    <volume>17</volume>(
                    <issue>2</issue>):
                    <fpage>153</fpage>–
                    <lpage>78</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jcf.2018.02.006</pub-id>
                    <pub-id pub-id-type="pmid">29506920</pub-id>
                    <issn>1569-1993</issn>
                </mixed-citation>
            </ref>
            <ref id="b19">
                <label>19. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Amitani</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Wilson</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Rutman</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Read</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Ward</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Burnett</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Effects of human neutrophil elastase and 
                        <italic>Pseudomonas aeruginosa</italic> proteinases on human respiratory epithelium
                    </article-title>. 
                    <source>Am J Respir Cell Mol Biol</source>. 
                    <year>1991</year>
                    <month>Jan</month>;
                    <volume>4</volume>(
                    <issue>1</issue>):
                    <fpage>26</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1165/ajrcmb/4.1.26</pub-id>
                    <pub-id pub-id-type="pmid">1898852</pub-id>
                    <issn>1044-1549</issn>
                </mixed-citation>
            </ref>
            <ref id="b20">
                <label>20. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wolter</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Seeney</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Bell</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Bowler</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Masel</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>McCormack</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial</article-title>. 
                    <source>Thorax</source>. 
                    <year>2002</year>
                    <month>Mar</month>;
                    <volume>57</volume>(
                    <issue>3</issue>):
                    <fpage>212</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thorax.57.3.212</pub-id>
                    <pub-id pub-id-type="pmid">11867823</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
            </ref>
            <ref id="b21">
                <label>21. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Saiman</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Marshall</surname>
                            <given-names>BC</given-names>
                        </name>, 
                        <name>
                            <surname>Mayer-Hamblett</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Burns</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Quittner</surname>
                            <given-names>AL</given-names>
                        </name>, 
                        <name>
                            <surname>Cibene</surname>
                            <given-names>DA</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Macrolide Study Group</collab>
                    </person-group>. 
                    <article-title>Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial</article-title>. 
                    <source>JAMA</source>. 
                    <year>2003</year>
                    <month>Oct</month>;
                    <volume>290</volume>(
                    <issue>13</issue>):
                    <fpage>1749</fpage>–
                    <lpage>56</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/jama.290.13.1749</pub-id>
                    <pub-id pub-id-type="pmid">14519709</pub-id>
                    <issn>0098-7484</issn>
                </mixed-citation>
            </ref>
            <ref id="b22">
                <label>22. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Clement</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Tamalet</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Leroux</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Ravilly</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Fauroux</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Jais</surname>
                            <given-names>JP</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial</article-title>. 
                    <source>Thorax</source>. 
                    <year>2006</year>
                    <month>Oct</month>;
                    <volume>61</volume>(
                    <issue>10</issue>):
                    <fpage>895</fpage>–
                    <lpage>902</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thx.2005.057950</pub-id>
                    <pub-id pub-id-type="pmid">16809416</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
            </ref>
            <ref id="b23">
                <label>23. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mayer-Hamblett</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Retsch-Bogart</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Kloster</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Accurso</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Rosenfeld</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Albers</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>OPTIMIZE Study Group</collab>
                    </person-group>. 
                    <article-title>Azithromycin for Early 
                        <italic>Pseudomonas</italic> Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial
                    </article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2018</year>
                    <month>Nov</month>;
                    <volume>198</volume>(
                    <issue>9</issue>):
                    <fpage>1177</fpage>–
                    <lpage>87</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.201802-0215OC</pub-id>
                    <pub-id pub-id-type="pmid">29890086</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b24">
                <label>24. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Saiman</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Anstead</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Mayer-Hamblett</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Lands</surname>
                            <given-names>LC</given-names>
                        </name>, 
                        <name>
                            <surname>Kloster</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Hocevar-Trnka</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>AZ0004 Azithromycin Study Group</collab>
                    </person-group>. 
                    <article-title>Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial</article-title>. 
                    <source>JAMA</source>. 
                    <year>2010</year>
                    <month>May</month>;
                    <volume>303</volume>(
                    <issue>17</issue>):
                    <fpage>1707</fpage>–
                    <lpage>15</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/jama.2010.563</pub-id>
                    <pub-id pub-id-type="pmid">20442386</pub-id>
                    <issn>0098-7484</issn>
                </mixed-citation>
            </ref>
            <ref id="b25">
                <label>25. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mogayzel</surname>
                            <given-names>PJ</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Naureckas</surname>
                            <given-names>ET</given-names>
                        </name>, 
                        <name>
                            <surname>Robinson</surname>
                            <given-names>KA</given-names>
                        </name>, 
                        <name>
                            <surname>Mueller</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Hadjiliadis</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Hoag</surname>
                            <given-names>JB</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Pulmonary Clinical Practice Guidelines Committee</collab>
                    </person-group>. 
                    <article-title>Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2013</year>
                    <month>Apr</month>;
                    <volume>187</volume>(
                    <issue>7</issue>):
                    <fpage>680</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.201207-1160OE</pub-id>
                    <pub-id pub-id-type="pmid">23540878</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b26">
                <label>26. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Olveira</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Padilla</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Martínez-García</surname>
                            <given-names>M-Á</given-names>
                        </name>, 
                        <name>
                            <surname>de la Rosa</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Girón</surname>
                            <given-names>R-M</given-names>
                        </name>, 
                        <name>
                            <surname>Vendrell</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry</article-title>. 
                    <source>Arch Bronconeumol</source>.
                    <year>2017</year>
                    <month>Jul</month>;
                    <volume>53</volume>(
                    <issue>7</issue>):
                    <fpage>366</fpage>–
                    <lpage>74</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.arbres.2016.12.003</pub-id>
                    <pub-id pub-id-type="pmid">28118936</pub-id>
                    <issn>0300-2896</issn> 
                </mixed-citation>
            </ref>
            <ref id="b27">
                <label>27. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gao</surname>
                            <given-names>YH</given-names>
                        </name>, 
                        <name>
                            <surname>Guan</surname>
                            <given-names>WJ</given-names>
                        </name>, 
                        <name>
                            <surname>Liu</surname>
                            <given-names>SX</given-names>
                        </name>, 
                        <name>
                            <surname>Wang</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Cui</surname>
                            <given-names>JJ</given-names>
                        </name>, 
                        <name>
                            <surname>Chen</surname>
                            <given-names>RC</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Aetiology of bronchiectasis in adults: A systematic literature review</article-title>. 
                    <source>Respirology</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>21</volume>(
                    <issue>8</issue>):
                    <fpage>1376</fpage>–
                    <lpage>83</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/resp.12832</pub-id>
                    <pub-id pub-id-type="pmid">27321896</pub-id>
                    <issn>1323-7799</issn>
                </mixed-citation>
            </ref>
            <ref id="b28">
                <label>28. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Altenburg</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>de Graaff</surname>
                            <given-names>CS</given-names>
                        </name>, 
                        <name>
                            <surname>Stienstra</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Sloos</surname>
                            <given-names>JH</given-names>
                        </name>, 
                        <name>
                            <surname>van Haren</surname>
                            <given-names>EH</given-names>
                        </name>, 
                        <name>
                            <surname>Koppers</surname>
                            <given-names>RJ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial</article-title>. 
                    <source>JAMA</source>. 
                    <year>2013</year>
                    <month>Mar</month>;
                    <volume>309</volume>(
                    <issue>12</issue>):
                    <fpage>1251</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/jama.2013.1937</pub-id>
                    <pub-id pub-id-type="pmid">23532241</pub-id>
                    <issn>0098-7484</issn>
                </mixed-citation>
            </ref>
            <ref id="b29">
                <label>29. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wong</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Jayaram</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Karalus</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Eaton</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Tong</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Hockey</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial</article-title>. 
                    <source>Lancet</source>. 
                    <year>2012</year>
                    <month>Aug</month>;
                    <volume>380</volume>(
                    <issue>9842</issue>):
                    <fpage>660</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60953-2</pub-id>
                    <pub-id pub-id-type="pmid">22901887</pub-id>
                    <issn>0140-6736</issn>
                </mixed-citation>
            </ref>
            <ref id="b30">
                <label>30. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Serisier</surname>
                            <given-names>DJ</given-names>
                        </name>, 
                        <name>
                            <surname>Martin</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>McGuckin</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Lourie</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Chen</surname>
                            <given-names>AC</given-names>
                        </name>, 
                        <name>
                            <surname>Brain</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial</article-title>. 
                    <source>JAMA</source>. 
                    <year>2013</year>
                    <month>Mar</month>;
                    <volume>309</volume>(
                    <issue>12</issue>):
                    <fpage>1260</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/jama.2013.2290</pub-id>
                    <pub-id pub-id-type="pmid">23532242</pub-id>
                    <issn>0098-7484</issn>
                </mixed-citation>
            </ref>
            <ref id="b31">
                <label>31. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Polverino</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Goeminne</surname>
                            <given-names>PC</given-names>
                        </name>, 
                        <name>
                            <surname>McDonnell</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Aliberti</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Marshall</surname>
                            <given-names>SE</given-names>
                        </name>, 
                        <name>
                            <surname>Loebinger</surname>
                            <given-names>MR</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>European Respiratory Society guidelines for the management of adult bronchiectasis</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2017</year>
                    <month>Sep</month>;
                    <volume>50</volume>(
                    <issue>3</issue>):
                    <fpage>1700629</fpage>. 
                    <pub-id pub-id-type="doi">10.1183/13993003.00629-2017</pub-id>
                    <pub-id pub-id-type="pmid">28889110</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
            </ref>
            <ref id="b32">
                <label>32. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Barnes</surname>
                            <given-names>PJ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The cytokine network in asthma and chronic obstructive pulmonary disease</article-title>. 
                    <source>J Clin Invest</source>. 
                    <year>2008</year>
                    <month>Nov</month>;
                    <volume>118</volume>(
                    <issue>11</issue>):
                    <fpage>3546</fpage>–
                    <lpage>56</lpage>. 
                    <pub-id pub-id-type="doi">10.1172/JCI36130</pub-id>
                    <pub-id pub-id-type="pmid">18982161</pub-id>
                    <issn>0021-9738</issn>
                </mixed-citation>
            </ref>
            <ref id="b33">
                <label>33. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bhowmik</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Seemungal</surname>
                            <given-names>TA</given-names>
                        </name>, 
                        <name>
                            <surname>Sapsford</surname>
                            <given-names>RJ</given-names>
                        </name>, 
                        <name>
                            <surname>Wedzicha</surname>
                            <given-names>JA</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations</article-title>. 
                    <source>Thorax</source>. 
                    <year>2000</year>
                    <month>Feb</month>;
                    <volume>55</volume>(
                    <issue>2</issue>):
                    <fpage>114</fpage>–
                    <lpage>20</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thorax.55.2.114</pub-id>
                    <pub-id pub-id-type="pmid">10639527</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
            </ref>
            <ref id="b34">
                <label>34. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Huckle</surname>
                            <given-names>AW</given-names>
                        </name>, 
                        <name>
                            <surname>Fairclough</surname>
                            <given-names>LC</given-names>
                        </name>, 
                        <name>
                            <surname>Todd</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Prophylactic Antibiotic Use in COPD and the Potential Anti-Inflammatory Activities of Antibiotics</article-title>. 
                    <source>Respir Care</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>63</volume>(
                    <issue>5</issue>):
                    <fpage>609</fpage>–
                    <lpage>19</lpage>. 
                    <pub-id pub-id-type="doi">10.4187/respcare.05943</pub-id>
                    <pub-id pub-id-type="pmid">29463692</pub-id>
                    <issn>0020-1324</issn>
                </mixed-citation>
            </ref>
            <ref id="b35">
                <label>35. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Albert</surname>
                            <given-names>RK</given-names>
                        </name>, 
                        <name>
                            <surname>Connett</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Bailey</surname>
                            <given-names>WC</given-names>
                        </name>, 
                        <name>
                            <surname>Casaburi</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Cooper</surname>
                            <given-names>JA</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Criner</surname>
                            <given-names>GJ</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>COPD Clinical Research Network</collab>
                    </person-group>. 
                    <article-title>Azithromycin for prevention of exacerbations of COPD</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2011</year>
                    <month>Aug</month>;
                    <volume>365</volume>(
                    <issue>8</issue>):
                    <fpage>689</fpage>–
                    <lpage>98</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1104623</pub-id>
                    <pub-id pub-id-type="pmid">21864166</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b36">
                <label>36. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Uzun</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Djamin</surname>
                            <given-names>RS</given-names>
                        </name>, 
                        <name>
                            <surname>Kluytmans</surname>
                            <given-names>JA</given-names>
                        </name>, 
                        <name>
                            <surname>Mulder</surname>
                            <given-names>PG</given-names>
                        </name>, 
                        <name>
                            <surname>van’t Veer</surname>
                            <given-names>NE</given-names>
                        </name>, 
                        <name>
                            <surname>Ermens</surname>
                            <given-names>AA</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial</article-title>. 
                    <source>Lancet Respir Med</source>. 
                    <year>2014</year>
                    <month>May</month>;
                    <volume>2</volume>(
                    <issue>5</issue>):
                    <fpage>361</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S2213-2600(14)70019-0</pub-id>
                    <pub-id pub-id-type="pmid">24746000</pub-id>
                    <issn>2213-2600</issn>
                </mixed-citation>
            </ref>
            <ref id="b37">
                <label>37. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pomares</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <name>
                            <surname>Montón</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Bullich</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Cuevas</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <name>
                            <surname>Oliva</surname>
                            <given-names>JC</given-names>
                        </name>, 
                        <name>
                            <surname>Gallego</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment</article-title>. 
                    <source>Chest</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>153</volume>(
                    <issue>5</issue>):
                    <fpage>1125</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.chest.2018.01.044</pub-id>
                    <pub-id pub-id-type="pmid">29427576</pub-id>
                    <issn>0012-3692</issn>
                </mixed-citation>
            </ref>
            <ref id="b38">
                <label>38. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Naderi</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Assayag</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Mostafavi-Pour-Manshadi</surname>
                            <given-names>SM</given-names>
                        </name>, 
                        <name>
                            <surname>Kaddaha</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Joubert</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Ouellet</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease</article-title>. 
                    <source>Respir Med</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>138</volume>:
                    <fpage>129</fpage>–
                    <lpage>36</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.rmed.2018.03.035</pub-id>
                    <pub-id pub-id-type="pmid">29724384</pub-id>
                    <issn>0954-6111</issn>
                </mixed-citation>
            </ref>
            <ref id="b39">
                <label>39. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Haldar</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Pavord</surname>
                            <given-names>ID</given-names>
                        </name>, 
                        <name>
                            <surname>Shaw</surname>
                            <given-names>DE</given-names>
                        </name>, 
                        <name>
                            <surname>Berry</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Thomas</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Brightling</surname>
                            <given-names>CE</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cluster analysis and clinical asthma phenotypes</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2008</year>
                    <month>Aug</month>;
                    <volume>178</volume>(
                    <issue>3</issue>):
                    <fpage>218</fpage>–
                    <lpage>24</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.200711-1754OC</pub-id>
                    <pub-id pub-id-type="pmid">18480428</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b40">
                <label>40. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pavord</surname>
                            <given-names>ID</given-names>
                        </name>, 
                        <name>
                            <surname>Brightling</surname>
                            <given-names>CE</given-names>
                        </name>, 
                        <name>
                            <surname>Woltmann</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Wardlaw</surname>
                            <given-names>AJ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Non-eosinophilic corticosteroid unresponsive asthma</article-title>. 
                    <source>Lancet</source>. 
                    <year>1999</year>
                    <month>Jun</month>;
                    <volume>353</volume>(
                    <issue>9171</issue>):
                    <fpage>2213</fpage>–
                    <lpage>4</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(99)01813-9</pub-id>
                    <pub-id pub-id-type="pmid">10392993</pub-id>
                    <issn>0140-6736</issn>
                </mixed-citation>
            </ref>
            <ref id="b41">
                <label>41. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Brusselle</surname>
                            <given-names>GG</given-names>
                        </name>, 
                        <name>
                            <surname>Vanderstichele</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Jordens</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Deman</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Slabbynck</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Ringoet</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial</article-title>. 
                    <source>Thorax</source>. 
                    <year>2013</year>
                    <month>Apr</month>;
                    <volume>68</volume>(
                    <issue>4</issue>):
                    <fpage>322</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-202698</pub-id>
                    <pub-id pub-id-type="pmid">23291349</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
            </ref>
            <ref id="b42">
                <label>42. </label> 
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Global Initiative for Asthma</collab>
                    </person-group>. 
                    <source>Global Strategy for Asthma Management and Prevention</source>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-08-01">cited 2019 Aug 01</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.ginaasthma.org/</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b43">
                <label>43. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Esteban-Gorgojo</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Antolín-Amérigo</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Domínguez-Ortega</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Quirce</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Non-eosinophilic asthma: current perspectives</article-title>. 
                    <source>J Asthma Allergy</source>. 
                    <year>2018</year>
                    <month>Oct</month>;
                    <volume>11</volume>:
                    <fpage>267</fpage>–
                    <lpage>81</lpage>. 
                    <pub-id pub-id-type="doi">10.2147/JAA.S153097</pub-id>
                    <pub-id pub-id-type="pmid">30464537</pub-id>
                    <issn>1178-6965</issn>
                </mixed-citation>
            </ref>
            <ref id="b44">
                <label>44. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gauthier</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Hachem</surname>
                            <given-names>RR</given-names>
                        </name>, 
                        <name>
                            <surname>Kreisel</surname>
                            <given-names>D</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Update on Chronic Lung Allograft Dysfunction</article-title>.
                    <source>Curr Transplant reports</source>. 
                    <year>2016</year>
                    <month>Sep</month>;
                    <volume>3</volume>(
                    <issue>3</issue>):
                    <fpage>185</fpage>–
                    <lpage>91</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s40472-016-0112-y</pub-id>
                    <pub-id pub-id-type="pmid">28090432</pub-id>
                    <issn>2196-3029</issn>
                </mixed-citation>
            </ref>
            <ref id="b45">
                <label>45. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gerhardt</surname>
                            <given-names>SG</given-names>
                        </name>, 
                        <name>
                            <surname>McDyer</surname>
                            <given-names>JF</given-names>
                        </name>, 
                        <name>
                            <surname>Girgis</surname>
                            <given-names>RE</given-names>
                        </name>, 
                        <name>
                            <surname>Conte</surname>
                            <given-names>JV</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>SC</given-names>
                        </name>, 
                        <name>
                            <surname>Orens</surname>
                            <given-names>JB</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2003</year>
                    <month>Jul</month>;
                    <volume>168</volume>(
                    <issue>1</issue>):
                    <fpage>121</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.200212-1424BC</pub-id>
                    <pub-id pub-id-type="pmid">12672648</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b46">
                <label>46. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Verleden</surname>
                            <given-names>GM</given-names>
                        </name>, 
                        <name>
                            <surname>Vanaudenaerde</surname>
                            <given-names>BM</given-names>
                        </name>, 
                        <name>
                            <surname>Dupont</surname>
                            <given-names>LJ</given-names>
                        </name>, 
                        <name>
                            <surname>Van Raemdonck</surname>
                            <given-names>DE</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2006</year>
                    <month>Sep</month>;
                    <volume>174</volume>(
                    <issue>5</issue>):
                    <fpage>566</fpage>–
                    <lpage>70</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.200601-071OC</pub-id>
                    <pub-id pub-id-type="pmid">16741151</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b47">
                <label>47. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hansen</surname>
                            <given-names>MP</given-names>
                        </name>, 
                        <name>
                            <surname>Scott</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <name>
                            <surname>McCullough</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Thorning</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Aronson</surname>
                            <given-names>JK</given-names>
                        </name>, 
                        <name>
                            <surname>Beller</surname>
                            <given-names>EM</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Adverse events in people taking macrolide antibiotics versus placebo for any indication</article-title>. 
                    <source>Cochrane Database Syst Rev</source>. 
                    <year>2019</year>
                    <month>Jan</month>;
                    <volume>1</volume>:
                    <fpage>CD011825</fpage>. 
                    <pub-id pub-id-type="doi">10.1002/14651858.CD011825.pub2</pub-id>
                    <pub-id pub-id-type="pmid">30656650</pub-id>
                    <issn>1469-493X</issn>
                </mixed-citation>
            </ref>
            <ref id="b48">
                <label>48. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ray</surname>
                            <given-names>WA</given-names>
                        </name>, 
                        <name>
                            <surname>Murray</surname>
                            <given-names>KT</given-names>
                        </name>, 
                        <name>
                            <surname>Hall</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Arbogast</surname>
                            <given-names>PG</given-names>
                        </name>, 
                        <name>
                            <surname>Stein</surname>
                            <given-names>CM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Azithromycin and the risk of cardiovascular death</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2012</year>
                    <month>May</month>;
                    <volume>366</volume>(
                    <issue>20</issue>):
                    <fpage>1881</fpage>–
                    <lpage>90</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1003833</pub-id>
                    <pub-id pub-id-type="pmid">22591294</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b49">
                <label>49. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Grayston</surname>
                            <given-names>JT</given-names>
                        </name>, 
                        <name>
                            <surname>Kronmal</surname>
                            <given-names>RA</given-names>
                        </name>, 
                        <name>
                            <surname>Jackson</surname>
                            <given-names>LA</given-names>
                        </name>, 
                        <name>
                            <surname>Parisi</surname>
                            <given-names>AF</given-names>
                        </name>, 
                        <name>
                            <surname>Muhlestein</surname>
                            <given-names>JB</given-names>
                        </name>, 
                        <name>
                            <surname>Cohen</surname>
                            <given-names>JD</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>ACES Investigators</collab>
                    </person-group>. 
                    <article-title>Azithromycin for the secondary prevention of coronary events</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2005</year>
                    <month>Apr</month>;
                    <volume>352</volume>(
                    <issue>16</issue>):
                    <fpage>1637</fpage>–
                    <lpage>45</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa043526</pub-id>
                    <pub-id pub-id-type="pmid">15843666</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b50">
                <label>50. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bergman</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Huikko</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Huovinen</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Paakkari</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Seppälä</surname>
                            <given-names>H</given-names>
                        </name>; 
                        <collab>Finnish Study Group for Antimicrobial Resistance (FiRe Network)</collab>
                    </person-group>. 
                    <article-title>Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae</article-title>. 
                    <source>Antimicrob Agents Chemother</source>. 
                    <year>2006</year>
                    <month>Nov</month>;
                    <volume>50</volume>(
                    <issue>11</issue>):
                    <fpage>3646</fpage>–
                    <lpage>50</lpage>. 
                    <pub-id pub-id-type="doi">10.1128/AAC.00234-06</pub-id>
                    <pub-id pub-id-type="pmid">16940064</pub-id>
                    <issn>0066-4804</issn>
                </mixed-citation>
            </ref>
            <ref id="b51">
                <label>51. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cizman</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The use and resistance to antibiotics in the community</article-title>. 
                    <source>Int J Antimicrob Agents</source>. 
                    <year>2003</year>
                    <month>Apr</month>;
                    <volume>21</volume>(
                    <issue>4</issue>):
                    <fpage>297</fpage>–
                    <lpage>307</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0924-8579(02)00394-1</pub-id>
                    <pub-id pub-id-type="pmid">12672574</pub-id>
                    <issn>0924-8579</issn>
                </mixed-citation>
            </ref>
            <ref id="b52">
                <label>52. </label> 
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Čizman</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Bajec</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Korošec</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <source>Poraba antibiotikov v Sloveniji in drugod po svetu</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-08-22">cited 2019 Aug 22</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.szpz.info/content/2018/podiplomskitecaj/Milan_Cizman_Tom_Bajec_Ales_Korosec-Poraba_antibiotikov_v_sloveniji_in_drugod.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b53">
                <label>53. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Paragi</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Mioč</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Kastrin</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Kraigher</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Čretnik Žohar</surname>
                            <given-names>T</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Slovenska skupina za meningitise. Invazivne pnevmokokne okužbe po uvedbi cepljenja s konjugiranim cepivom v nacionalni program cepljenja</article-title>. 
                    <source>Med Razgl</source>. 
                    <year>2016</year>;
                    <volume>55</volume>
                    <supplement>Suppl 4</supplement>:
                    <fpage>121</fpage>–
                    <lpage>31</lpage>.
                    <issn>0025-8121</issn>
                </mixed-citation>
            </ref>
            <ref id="b54">
                <label>54. </label> 
                <mixed-citation publication-type="webpage">
                    <person-group><name><surname></surname></name></person-group>
                    <source>Pregled občutljivosti  bakterij  za  antibiotike. Slovenija 2011</source>. 
                   [<date-in-citation content-type="access-date" iso-8601-date="2019-08-22">cited 2019 Aug 22</date-in-citation>].
                    <comment>Available from:<uri>http://www.imi.si/strokovna-zdruzenja/skuopz/dokumenti/bakterijska-obcutljivost-v-sloveniji-2011.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b55">
                <label>55. </label> 
                <mixed-citation publication-type="webpage">
                    <person-group><name><surname></surname></name></person-group>
                    <source>Pregled občutljivosti  bakterij  za  antibiotike. Slovenija 2017</source>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-08-22">cited 2019 Aug 22</date-in-citation>].
                    <comment>Available from:<uri>http://www.imi.si/strokovna-zdruzenja/skuopz/dokumenti/skoupz_porocilo_2017_CIP.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b56">
                <label>56. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kastner</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <name>
                            <surname>Guggenbichler</surname>
                            <given-names>JP</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Influence of macrolide antibiotics on promotion of resistance in the oral flora of children</article-title>. 
                    <source>Infection</source>. 
                    <year>2001</year>
                    <month>Oct</month>;
                    <volume>29</volume>(
                    <issue>5</issue>):
                    <fpage>251</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s15010-001-1072-3</pub-id>
                    <pub-id pub-id-type="pmid">11688901</pub-id>
                    <issn>0300-8126</issn>
                </mixed-citation>
            </ref>
            <ref id="b57">
                <label>57. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Taylor</surname>
                            <given-names>SL</given-names>
                        </name>, 
                        <name>
                            <surname>Leong</surname>
                            <given-names>LEX</given-names>
                        </name>, 
                        <name>
                            <surname>Mobegi</surname>
                            <given-names>FM</given-names>
                        </name>, 
                        <name>
                            <surname>Choo</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Wesselingh</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>IA</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2019</year>
                    <month>Aug</month>;
                    <volume>200</volume>(
                    <issue>3</issue>):
                    <fpage>309</fpage>–
                    <lpage>17</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.201809-1739OC</pub-id>
                    <pub-id pub-id-type="pmid"> 30875247</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b58">
                <label>58. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tramper-Stranders</surname>
                            <given-names>GA</given-names>
                        </name>, 
                        <name>
                            <surname>Wolfs</surname>
                            <given-names>TF</given-names>
                        </name>, 
                        <name>
                            <surname>Fleer</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Kimpen</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>van der Ent</surname>
                            <given-names>CK</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function</article-title>. 
                    <source>Pediatr Infect Dis J</source>. 
                    <year>2007</year>
                    <month>Jan</month>;
                    <volume>26</volume>(
                    <issue>1</issue>):
                    <fpage>8</fpage>–
                    <lpage>12</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/01.inf.0000247109.44249.ac</pub-id>
                    <pub-id pub-id-type="pmid">17195698</pub-id>
                    <issn>0891-3668</issn>
                </mixed-citation>
            </ref>
            <ref id="b59">
                <label>59. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tramper-Stranders</surname>
                            <given-names>GA</given-names>
                        </name>, 
                        <name>
                            <surname>van der Ent</surname>
                            <given-names>CK</given-names>
                        </name>, 
                        <name>
                            <surname>Gerritsen</surname>
                            <given-names>SA</given-names>
                        </name>, 
                        <name>
                            <surname>Fleer</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Kimpen</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Wolfs</surname>
                            <given-names>TF</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?</article-title>
                    <source>J Antimicrob Chemother</source>. 
                    <year>2007</year>
                    <month>Sep</month>;
                    <volume>60</volume>(
                    <issue>3</issue>):
                    <fpage>665</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jac/dkm235</pub-id>
                    <pub-id pub-id-type="pmid">17604321</pub-id>
                    <issn>0305-7453</issn>
                </mixed-citation>
            </ref>
            <ref id="b60">
                <label>60. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Megraud</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Coenen</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Versporten</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Kist</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Lopez-Brea</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Hirschl</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Study Group participants</collab>
                    </person-group>. 
                    <article-title>Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption</article-title>. 
                    <source>Gut</source>. 
                    <year>2013</year>
                    <month>Jan</month>;
                    <volume>62</volume>(
                    <issue>1</issue>):
                    <fpage>34</fpage>–
                    <lpage>42</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/gutjnl-2012-302254</pub-id>
                    <pub-id pub-id-type="pmid">22580412</pub-id>
                    <issn>0017-5749</issn>
                </mixed-citation>
            </ref>
            <ref id="b61">
                <label>61. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tepeš</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Vujasinović</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Šeruga</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Stefanovič</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Forte</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Jeverica</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication</article-title>. 
                    <source>Eur J Gastroenterol Hepatol</source>. 
                    <year>2016</year>
                    <month>Jun</month>;
                    <volume>28</volume>(
                    <issue>6</issue>):
                    <fpage>676</fpage>–
                    <lpage>83</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/MEG.0000000000000590</pub-id>
                    <pub-id pub-id-type="pmid">26862930</pub-id>
                    <issn>0954-691X</issn>
                </mixed-citation>
            </ref>
            <ref id="b62">
                <label>62. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Haworth</surname>
                            <given-names>CS</given-names>
                        </name>, 
                        <name>
                            <surname>Banks</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Capstick</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Fisher</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Gorsuch</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Laurenson</surname>
                            <given-names>IF</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)</article-title>. 
                    <source>Thorax</source>. 
                    <year>2017</year>
                    <month>Nov</month>;
                    <volume>72</volume>
                    <supplement>Suppl 2</supplement>:
                    <fpage>ii1</fpage>–
                    <lpage>64</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-210927</pub-id>
                    <pub-id pub-id-type="pmid">29054853</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
            </ref>
            <ref id="b63">
                <label>63. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Griffith</surname>
                            <given-names>DE</given-names>
                        </name>, 
                        <name>
                            <surname>Aksamit</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Brown-Elliott</surname>
                            <given-names>BA</given-names>
                        </name>, 
                        <name>
                            <surname>Catanzaro</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Daley</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Gordin</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>ATS Mycobacterial Diseases Subcommittee</collab>; 
                        <collab>American Thoracic Society</collab>; 
                        <collab>Infectious Disease Society of America</collab>
                    </person-group>. 
                    <article-title>An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases</article-title>. 
                    <source>Am J Respir Crit Care Med</source>. 
                    <year>2007</year>
                    <month>Feb</month>;
                    <volume>175</volume>(
                    <issue>4</issue>):
                    <fpage>367</fpage>–
                    <lpage>416</lpage>. 
                    <pub-id pub-id-type="doi">10.1164/rccm.200604-571ST</pub-id>
                    <pub-id pub-id-type="pmid">17277290</pub-id>
                    <issn>1073-449X</issn>
                </mixed-citation>
            </ref>
            <ref id="b64">
                <label>64. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Grosset</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Ji</surname>
                            <given-names>B</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex</article-title>. 
                    <source>Drugs</source>. 
                    <year>1997</year>;
                    <volume>54</volume>
                    <supplement>Suppl 2</supplement>:
                    <fpage>23</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.2165/00003495-199700542-00006</pub-id>
                    <pub-id pub-id-type="pmid">9358197</pub-id>
                    <issn>0012-6667</issn>
                </mixed-citation>
            </ref>
            <ref id="b65">
                <label>65. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hosono</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Kitada</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Yano</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Mori</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Miki</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Miki</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study</article-title>. 
                    <source>J Infect Chemother</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>24</volume>(
                    <issue>5</issue>):
                    <fpage>353</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jiac.2017.12.008</pub-id>
                    <pub-id pub-id-type="pmid">29361415</pub-id>
                    <issn>1341-321X</issn>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>